<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="utf8">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Risteys – T2D – detailed case counts by code</title>
		<style type="text/css">
body {
	font-family: sans-serif;
}
.bar-plot-full {
	width: 8rem;
	border-radius: 0.1rem;
	background-color: #f2f2f2;
}
.bar-plot-full div {
	background-color: #c7c7c7;
	height: 1rem;
	border-radius: 0.1rem;
}
		</style>
	</head>
	<body>

		<table>
			<tr>
				<th>Source</th>
				<th>Code</th>
				<th>Name</th>
				<th>Case count</th>
				<th>Share of cases (%)</th>
			</tr>

			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BA02)</td>
					<td>Metformin</td>
					<td>43387</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 88.33937370199943%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E11)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus</td>
					<td>29905</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 60.88895223357902%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E11)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus</td>
					<td>27386</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 55.76006841226534%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>23029</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 46.888870790405996%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>20106</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 40.937410921529505%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>17820</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 36.282933583092394%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>16960</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 34.53190536303295%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH01)</td>
					<td>Sitagliptin</td>
					<td>12548</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 25.548723378262817%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB12)</td>
					<td>Glimepiride</td>
					<td>9188</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 18.707496844077045%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK03)</td>
					<td>Empagliflozin</td>
					<td>6122</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 12.464877631632529%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>5263</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 10.715885490898726%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E119)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>4893</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.96253614040803%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD07)</td>
					<td>Metformin and sitagliptin</td>
					<td>4865</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.905525919289815%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>4778</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.72838701795822%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E119)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>4764</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.699881907399112%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH05)</td>
					<td>Linagliptin</td>
					<td>4507</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.176609520706927%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB01)</td>
					<td>Glibenclamide</td>
					<td>4308</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.771429734902473%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>3956</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.054729812273486%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK01)</td>
					<td>Dapagliflozin</td>
					<td>3217</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.550067190617746%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX01)</td>
					<td>Guar gum</td>
					<td>3135</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.383108685914403%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E11)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus</td>
					<td>2706</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.509630655210327%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E11)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus</td>
					<td>2509</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.1085230280571725%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>2478</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.045404568962007%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BG03)</td>
					<td>Pioglitazone</td>
					<td>2471</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.031152013682453%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>2393</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.872337826281712%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>2371</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.8275440811174%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>2257</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.59543103799324%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ02)</td>
					<td>Liraglutide</td>
					<td>2188</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.454941564523353%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>2099</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.273730504540457%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH02)</td>
					<td>Vildagliptin</td>
					<td>1958</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.9866433196237323%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>1896</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.8604064014334%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1832</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.730097324591766%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E11)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus</td>
					<td>1721</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.504092519444558%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>1713</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.4878038848393538%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1614</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.286232031599951%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2500A)</td>
					<td>Diabetes mellitus without mention of complication</td>
					<td>1579</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.2149692552021825%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus</td>
					<td>1482</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.0174695606140816%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD03)</td>
					<td>Metformin and rosiglitazone</td>
					<td>1411</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.872907928492894%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BG02)</td>
					<td>Rosiglitazone</td>
					<td>1323</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.6937329478356475%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>1225</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.494197173921896%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX07)</td>
					<td>Liraglutide</td>
					<td>1202</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.447367349431934%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>1198</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.439223032129332%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB07)</td>
					<td>Glipizide</td>
					<td>1186</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.4147900802215254%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E11)</td>
					<td>Non-insulin-dependent diabetes mellitus</td>
					<td>1077</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.192857433725618%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX02)</td>
					<td>Repaglinide</td>
					<td>992</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.019790691045323%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX04)</td>
					<td>Exenatide</td>
					<td>964</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.9627804699271083%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>886</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.8039662825263671%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>854</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.7388117441055502%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>824</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6777293643360347%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E11)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus</td>
					<td>822</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6736572056847334%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>807</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6431160157999756%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX09)</td>
					<td>Dapagliflozin</td>
					<td>804</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.637007777823024%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E11)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus</td>
					<td>794</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6166469845665186%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>785</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.598322270635664%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ01)</td>
					<td>Exenatide</td>
					<td>759</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5453842081687503%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ06)</td>
					<td>Name not found</td>
					<td>757</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5413120495174493%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD08)</td>
					<td>Metformin and vildagliptin</td>
					<td>719</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.463941035142729%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E119)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>590</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.2012868021338112%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E118)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>583</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1870342468542576%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>579</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1788899295516555%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E118)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>575</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1707456122490532%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>529</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.077085963269129%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ05)</td>
					<td>Dulaglutide</td>
					<td>518</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0546890906869733%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>513</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0445086940587205%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>509</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0363643767561184%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD20)</td>
					<td>Metformin and empagliflozin</td>
					<td>498</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0139675041739626%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E119)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>471</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9589933623813983%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>464</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9447408071018447%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>421</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.857189396098872%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD15)</td>
					<td>Metformin and dapagliflozin</td>
					<td>405</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8246121268884635%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD05)</td>
					<td>Metformin and pioglitazone</td>
					<td>404</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8225760475628131%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>378</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7696379850958993%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E11)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus</td>
					<td>337</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6861587327442277%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(310)_ICD10(E11)</td>
					<td>Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus</td>
					<td>314</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6393289082542656%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>261</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.5314167039947877%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD11)</td>
					<td>Metformin and linagliptin</td>
					<td>235</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.47847864152787395%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E119)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>232</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.47237040355092236%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>192</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3909272305249013%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E119)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>171</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.34816956468624016%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>160</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3257726921040844%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH03)</td>
					<td>Saxagliptin</td>
					<td>160</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3257726921040844%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2507A)</td>
					<td>Diabetes mellitus, Diabetes with peripheral circulatory disorders</td>
					<td>140</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.28505110559107383%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>137</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.27894286761412224%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1101)</td>
					<td>Non-insulin dependent diabetes diabetic coma with hyperglycaemia</td>
					<td>117</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2382212811011117%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>111</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.22600480514720855%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2505A)</td>
					<td>Diabetes mellitus, Diabetes with ophthalmic manifestations</td>
					<td>106</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2158244085189559%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX12)</td>
					<td>Empagliflozin</td>
					<td>104</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.21175224986765487%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E119)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>84</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.17103066335464429%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E117)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>82</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.16695850470334325%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>78</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.15881418740074113%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E112)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>73</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1486337907724885%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E112)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>71</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.14456163212118744%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E118)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>70</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.14252555279553691%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2500A)</td>
					<td>Diabetes mellitus without mention of complication</td>
					<td>69</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.14048947346988638%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E117)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>65</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1323451561672843%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E118)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>64</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13030907684163376%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E117)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>60</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.12216475953903165%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11605652156208006%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1101)</td>
					<td>Non-insulin dependent diabetes diabetic coma with hyperglycaemia</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11605652156208006%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E114)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>56</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11402044223642954%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E114)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>55</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11198436291077901%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E116)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>53</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10791220425947795%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E112)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>51</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1038400456081769%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10180396628252637%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E116)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10180396628252637%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E112)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10180396628252637%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD19)</td>
					<td>Linagliptin and empagliflozin</td>
					<td>48</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09773180763122533%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E117)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>47</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09569572830557478%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E119)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>46</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09365964897992425%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>44</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0895874903286232%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH04)</td>
					<td>Alogliptin</td>
					<td>44</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0895874903286232%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX03)</td>
					<td>Nateglinide</td>
					<td>41</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08347925235167163%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD9(E11)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>37</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07533493504906952%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2503A)</td>
					<td>Diabetes mellitus, Diabetes with other coma</td>
					<td>35</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07126277639776846%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD10)</td>
					<td>Metformin and saxagliptin</td>
					<td>35</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07126277639776846%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2506A)</td>
					<td>Diabetes mellitus, Diabetes with neurological manifestations</td>
					<td>34</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06922669707211793%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E113)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>33</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06719061774646741%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2508A)</td>
					<td>Diabetes mellitus, Diabetes with other specified manifestations</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06515453842081688%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E113)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06515453842081688%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E110)</td>
					<td>Name not found</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06311845909516635%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E110)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06311845909516635%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E113)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06311845909516635%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E113)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06311845909516635%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK02)</td>
					<td>Kanagliflozin</td>
					<td>30</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.061082379769515825%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>28</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05701022111821477%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E110)</td>
					<td>Diabetes, non-insulin-treated, Name not found</td>
					<td>27</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05497414179256424%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E117)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05293806246691372%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E114)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05293806246691372%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2507A)</td>
					<td>Diabetes mellitus, Diabetes with peripheral circulatory disorders</td>
					<td>25</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.050901983141263187%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E114)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>24</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04886590381561266%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2504A)</td>
					<td>Diabetes mellitus, Diabetes with renal manifestations</td>
					<td>23</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.046829824489962125%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E117)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>23</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.046829824489962125%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E112)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>22</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0447937451643116%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04072158651301055%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E112)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04072158651301055%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E118)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04072158651301055%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E111)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03868550718736002%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E118)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03868550718736002%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E111)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>16</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03257726921040844%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD09)</td>
					<td>Pioglitazone and alogliptin</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.030541189884757913%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.028505110559107386%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E110)</td>
					<td>Name not found</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.028505110559107386%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD13)</td>
					<td>Metformin and alogliptin</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.028505110559107386%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E116)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.028505110559107386%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E112)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.028505110559107386%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>13</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02646903123345686%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ03)</td>
					<td>Lixisenatide</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02443295190780633%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK04)</td>
					<td>Name not found</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02443295190780633%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E114)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02443295190780633%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD21)</td>
					<td>Saxagliptin and dapagliflozin</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0223968725821558%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E115)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0223968725821558%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E116)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.020360793256505274%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E113)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.018324713930854747%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E114)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.018324713930854747%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E115)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.018324713930854747%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(310)_ICD10(E119)</td>
					<td>Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01628863460520422%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB02)</td>
					<td>Chlorpropamide</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.014252555279553693%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX10)</td>
					<td>Lixisenatid</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.014252555279553693%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E117)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.014252555279553693%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E116)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.012216475953903166%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E113)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.012216475953903166%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E118)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.012216475953903166%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2505A)</td>
					<td>Diabetes mellitus, Diabetes with ophthalmic manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010180396628252637%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2506A)</td>
					<td>Diabetes mellitus, Diabetes with neurological manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010180396628252637%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2508A)</td>
					<td>Diabetes mellitus, Diabetes with other specified manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010180396628252637%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E115)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010180396628252637%"></div>
						</div>
						
					</td>
				</tr>
			

		</table>

	</body>
</html>
